Caxton Associates (New York)’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,036
| Closed | -$715K | – | 638 |
|
|
2022
Q4 | $715K | Buy |
3,036
+1,519
| +100% | +$357K | 0.05% | 163 |
|
|
2022
Q3 | $373K | Buy |
+1,517
| New | +$373K | 0.05% | 276 |
|
|
2017
Q3 | – | Sell |
-5,000
| Closed | -$473K | – | 581 |
|
|
2017
Q2 | $473K | Sell |
5,000
-600
| -11% | -$56.8K | 0.02% | 302 |
|
|
2017
Q1 | $457K | Buy |
+5,600
| New | +$457K | ﹤0.01% | 221 |
|